Top 10 Medical AI Stocks on Wall Street’s Radar

8. Boston Scientific Corp (NYSE:BSX)

Number of Hedge Fund Holders: 60

Boston Scientific Corp (NYSE:BSX) is a biomedical engineering firm that manufactures medical devices used in interventional medical specialties, including cardiology, neurology, oncology, urology, and gynaecology. The company has heavily invested in AI-driven health solutions to streamline operations, enhance in-patient engagement for better care, and empower healthcare professionals with accurate data for faster and more accurate decision-making.

On January 21st, Barclays hiked Boston Scientific Corp’s (NYSE:BSX) target price to $111 from $86 and retained its “Overweight” rating. While the medtech industry outlook for 2025 will depend on factors like inflation, surgical volumes, and policy changes under the new US Administration, Barclays remains “generally bullish” on the fundamentals of most end markets. It highlighted that utilization appears to be ending the year at a “healthy clip,” and low unemployment rates favor continued healthcare utilization and surgical procedure growth.